Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Inhibitors

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Image of 2D Structure
Search for synonyms (with exact matching search term)

Search term:

Results 1 - 10 of 56 > >>
download as CSV
download all results as CSV
EC Number Inhibitors Commentary Structure
Show all pathways known for 6.3.2.10Display the word mapDisplay the reaction diagram Show all sequences 6.3.2.10(2R,4R)-4-(3,7-dimethoxynaphthalen-2-yl)-1-(dimethylamino)-3,4-diphenylbutan-2-ol modest activity against lipopolysaccharide-defective Escherichia coli and wild-type Escherichia coli rendered permeable with polymyxin B nonapeptide. Treatment of lipopolysaccharide-defective Escherichia coli cells with >2fold minimal inhibitory concentrations of DQ1 results in a 75-fold-greater accumulation of the MurF substrate compared to the control, a 70% decline in the amount of the MurF product, and eventual cell lysis, consistent with the inhibition of MurF within bacteria Go to the Ligand Summary Page
Show all pathways known for 6.3.2.10Display the word mapDisplay the reaction diagram Show all sequences 6.3.2.10(2S,4R)-4-(3,7-dimethoxynaphthalen-2-yl)-1-(dimethylamino)-3,4-diphenylbutan-2-ol additionally active against Gram-positive bacteria, including methicillin-susceptible and -resistant Staphylococcus aureus isolates and vancomycin-susceptible and -resistant Enterococcus faecalis and Enterococcus faecium isolates Go to the Ligand Summary Page
Show all pathways known for 6.3.2.10Display the word mapDisplay the reaction diagram Show all sequences 6.3.2.101,4-diaminoanthra-9,10-quinone pIC50 predicted by comparative residue interaction analysis: 5.0, pIC50 predicted by comparative molecular field analysis:5.5 Go to the Ligand Summary Page
Show all pathways known for 6.3.2.10Display the word mapDisplay the reaction diagram Show all sequences 6.3.2.101-(azepan-1-ylmethyl)-2-naphthol pIC50 predicted by comparative residue interaction analysis: 5.7, pIC50 predicted by comparative molecular field analysis: 5.9 Go to the Ligand Summary Page
Show all pathways known for 6.3.2.10Display the word mapDisplay the reaction diagram Show all sequences 6.3.2.101-(cyclohexylmethyl)piperazine pIC50 predicted by comparative residue interaction analysis: 5.5, pIC50 predicted by comparative molecular field analysis: 6.2 Go to the Ligand Summary Page
Show all pathways known for 6.3.2.10Display the word mapDisplay the reaction diagram Show all sequences 6.3.2.101-[[(4-trifluoromethylphenyl)sulfonyl]amino]-3-(morpholin-4-yl)propan-2-yl dihydrogen phosphate - Go to the Ligand Summary Page
Show all pathways known for 6.3.2.10Display the word mapDisplay the reaction diagram Show all sequences 6.3.2.102,4-dichloro-N-(3-cyano-4,5,6,6a-tetrahydro-3aH-cyclopenta[b]thien-2-yl)-5-(morpholin-4-ylsulfonyl)benzamide - Go to the Ligand Summary Page
Show all pathways known for 6.3.2.10Display the word mapDisplay the reaction diagram Show all sequences 6.3.2.102,4-dichloro-N-(3-cyano-4,5,6,6a-tetrahydro-3aH-cyclopenta[b]thien-2-yl)-5-[(diethylamino)sulfonyl]benzamide - Go to the Ligand Summary Page
Show all pathways known for 6.3.2.10Display the word mapDisplay the reaction diagram Show all sequences 6.3.2.102,4-dichloro-N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-5-(morpholin-4-ylsulfonyl)benzamide - Go to the Ligand Summary Page
Show all pathways known for 6.3.2.10Display the word mapDisplay the reaction diagram Show all sequences 6.3.2.102,4-dichloro-N-(3-cyano-6-phenyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-5-[(2-methoxyethyl)(methyl)sulfamoyl]benzamide - Go to the Ligand Summary Page
Results 1 - 10 of 56 > >>
download as CSV
download all results as CSV